IDO1/TDO dual inhibitor RY103 targets Kyn-AhR pathway and exhibits preclinical efficacy on pancreatic cancer
Heng Liang, Tianqi Li, Xin Fang, Zikang Xing, Shengnan Zhang, Lei Shi, Weirui Li, Leilei Guo, Chunxiang Kuang, Hongrui Liu, Qing Yang
Topics & Concepts
Pancreatic cancerCancer researchCancerDual (grammatical number)MedicinePharmacologyInternal medicineArtLiteratureTryptophan and brain disordersImmune cells in cancerEpigenetics and DNA Methylation